Effectiveness of oral administration of vitamin D in anemia of patients with type 2 diabetes with mild renal impairment
Phase 2
- Conditions
- anemia.
- Registration Number
- IRCT2016011125951N1
- Lead Sponsor
- Vice Chancellor for research of Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
inclusion criteria :all diabetic cases with anemia based on WHO criteria and mild renal impairment according to Staging ( KDIGO 2012
exclusion criteria:history of transfusion during 3 months ago/history of recent bleeding/history of recent infection during 2 months ago/history of supplement therapy/pregnancy/smoking/chronic disease of liver/kidney hypercalcemia/hyperparathyroidesim/explained anemia
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin and vitamin D before intervention and 8 weeks after interventin. Timepoint: before intervention and at the end of intervention ( end of second month). Method of measurement: enzyme immunoassay method (EIA) [immunodiagnostic system; IDS (LTD), UK].
- Secondary Outcome Measures
Name Time Method Srum 25 hydroxy vitamin D. Timepoint: 8 WEEKS. Method of measurement: enzyme immunoassay method (EIA).